Your browser doesn't support javascript.
loading
Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials.
Jiang, Tommy; Markovic, Daniela; Patel, Jay; Juarez, Jesus E; Ma, Ting Martin; Shabsovich, David; Nickols, Nicholas G; Reiter, Robert E; Elashoff, David; Rettig, Matthew B; Zaorsky, Nicholas G; Spratt, Daniel E; Kishan, Amar U.
Afiliação
  • Jiang T; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Markovic D; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Patel J; Department of Medicine, Statistics Core, University of California, Los Angeles, CA, USA.
  • Juarez JE; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Ma TM; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Shabsovich D; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Nickols NG; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Reiter RE; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Elashoff D; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Rettig MB; Department of Medicine, Statistics Core, University of California, Los Angeles, CA, USA.
  • Zaorsky NG; Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Spratt DE; Division of Hematology and Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
  • Kishan AU; Department of Radiation Oncology, Penn State Cancer Institute, Hershey, PA, USA.
Prostate Cancer Prostatic Dis ; 25(1): 126-128, 2022 03.
Article em En | MEDLINE | ID: mdl-34400799
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antagonistas de Androgênios Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Limite: Humans / Male Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antagonistas de Androgênios Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Limite: Humans / Male Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos